Who
David A. Rosa
CEO & President
Company insider
Files Form 4 as: CEO & President, NeuroOne Medical Technologies; Director, BioRestorative Therapies; Director, Healthcare Triangle; Director, Biotricity; Chief Executive Officer, Nuwellis.
In numbers
- Trades disclosed
- 96
- Buys
- 1
- Sells
- 5
- Bought
- $50K
- Sold
- $234K
- Companies
- 5
- Companies where not an officer
- 3
- First trade
- 6 May 2013
- Last trade
- 28 Aug 2026
- Last filed
- 28 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Aug 2026filed 28 Aug 2026 | NMTC NeuroOne Medical Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —68,000 at $0.00 | filing |
| 28 Aug 2026filed 28 Aug 2026 | NMTC NeuroOne Medical Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —68,000 at $0.00 | filing |
| 31 Mar 2026filed 1 Apr 2026 | NMTC NeuroOne Medical TechnologiesMedical Devices | SEC FORM 4 Code F | $1,9102,458 at $0.777 | filing |
| 31 Mar 2026filed 1 Apr 2026 | NMTC NeuroOne Medical TechnologiesMedical Devices | SEC FORM 4 Code F | $1,9172,458 at $0.78 | filing |
| 18 Feb 2026filed 20 Feb 2026 | NMTC NeuroOne Medical TechnologiesMedical Devices | SEC FORM 4 Code F | $49K71,325 at $0.68 | filing |
| 18 Feb 2026filed 20 Feb 2026 | NMTC NeuroOne Medical TechnologiesMedical Devices | SEC FORM 4 Code F | $49K71,325 at $0.68 | filing |
| 31 Dec 2025filed 5 Jan 2026 | NMTC NeuroOne Medical TechnologiesMedical Devices | SEC FORM 4 Code F | $1,8632,458 at $0.758 | filing |
| 31 Dec 2025filed 5 Jan 2026 | NMTC NeuroOne Medical TechnologiesMedical Devices | SEC FORM 4 Code F | $1,8682,458 at $0.76 | filing |
| 30 Sep 2025filed 1 Oct 2025 | NMTC NeuroOne Medical TechnologiesMedical Devices | SEC FORM 4 Code F | $2,1882,458 at $0.89 | filing |
| 30 Jun 2025filed 2 Jul 2025 | NMTC NeuroOne Medical TechnologiesMedical Devices | SEC FORM 4 Code F | $1,6712,458 at $0.68 | filing |
| 17 Apr 2025filed 21 Apr 2025 | NMTC NeuroOne Medical Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —750,000 at $0.00 | filing |
| 4 Apr 2025filed 7 Apr 2025 | NMTC NeuroOne Medical TechnologiesMedical Devices | SEC FORM 4 Bought | $50K100,000 at $0.50 | filing |
| 31 Mar 2025filed 2 Apr 2025 | NMTC NeuroOne Medical TechnologiesMedical Devices | SEC FORM 4 Code F | $2,0892,458 at $0.85 | filing |
| 18 Feb 2025filed 20 Feb 2025 | NMTC NeuroOne Medical TechnologiesMedical Devices | SEC FORM 4 Code F | $83K71,325 at $1.16 | filing |
| 14 Feb 2025filed 19 Feb 2025 | BRTX BioRestorative Therapiesoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —52,632 at $0.00 | filing |
| 31 Jan 2025filed 4 Feb 2025 | NMTC NeuroOne Medical TechnologiesMedical Devices | SEC FORM 4 Code F | $2,5752,239 at $1.15 | filing |
| 31 Dec 2024filed 3 Jan 2025 | NMTC NeuroOne Medical TechnologiesMedical Devices | SEC FORM 4 Code F | $3,8994,697 at $0.83 | filing |
| 30 Nov 2024filed 3 Dec 2024 | NMTC NeuroOne Medical TechnologiesMedical Devices | SEC FORM 4 Code F | $1,3882,239 at $0.62 | filing |
| 31 Oct 2024filed 1 Nov 2024 | NMTC NeuroOne Medical TechnologiesMedical Devices | SEC FORM 4 Code F | $2,1722,239 at $0.97 | filing |
| 30 Sep 2024filed 2 Oct 2024 | NMTC NeuroOne Medical TechnologiesMedical Devices | SEC FORM 4 Code F | $4,6504,697 at $0.99 | filing |
News
Comparing NeuroOne Medical Technologies (NASDAQ:NMTC) and Innovative Eyewear (NASDAQ:LUCY)NMTC · tickerreport.com · 11 Oct 2026
0 headlines in the last 90 days name David A. Rosa; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.